169 results on '"Michael, Kurz"'
Search Results
2. Genomic and Chemical Decryption of the Bacteroidetes Phylum for Its Potential to Biosynthesize Natural Products
- Author
-
Stephan Brinkmann, Michael Kurz, Maria A. Patras, Christoph Hartwig, Michael Marner, Benedikt Leis, André Billion, Yolanda Kleiner, Armin Bauer, Luigi Toti, Christoph Pöverlein, Peter E. Hammann, Andreas Vilcinskas, Jens Glaeser, Marius Spohn, and Till F. Schäberle
- Subjects
natural products ,antifungal ,NRPS ,metabolomics ,genomics ,Bacteroidetes ,Microbiology ,QR1-502 - Abstract
ABSTRACT With progress in genome sequencing and data sharing, 1,000s of bacterial genomes are publicly available. Genome mining—using bioinformatics tools in terms of biosynthetic gene cluster (BGC) identification, analysis, and rating—has become a key technology to explore the capabilities for natural product (NP) biosynthesis. Comprehensively, analyzing the genetic potential of the phylum Bacteroidetes revealed Chitinophaga as the most talented genus in terms of BGC abundance and diversity. Guided by the computational predictions, we conducted a metabolomics and bioactivity driven NP discovery program on 25 Chitinophaga strains. High numbers of strain-specific metabolite buckets confirmed the upfront predicted biosynthetic potential and revealed a tremendous uncharted chemical space. Mining this data set, we isolated the new iron chelating nonribosomally synthesized cyclic tetradeca- and pentadecalipodepsipeptide antibiotics chitinopeptins with activity against Candida, produced by C. eiseniae DSM 22224 and C. flava KCTC 62435, respectively. IMPORTANCE The development of pipelines for anti-infectives to be applied in plant, animal, and human health management are dried up. However, the resistance development against compounds in use calls for new lead structures. To fill this gap and to enhance the probability of success for the discovery of new bioactive natural products, microbial taxa currently underinvestigated must be mined. This study investigates the potential within the bacterial phylum Bacteroidetes. A combination of omics-technologies revealed taxonomical hot spots for specialized metabolites. Genome- and metabolome-based analyses showed that the phylum covers a new chemical space compared with classic natural product producers. Members of the Bacteroidetes may thus present a promising bioresource for future screening and isolation campaigns.
- Published
- 2022
- Full Text
- View/download PDF
3. Redescription of the alpine Incurvaria stangei Rebel, 1903 (Lepidoptera, Incurvariidae), reinstated from Prodoxidae
- Author
-
Benjamin Wiesmair, Peter Buchner, Michael Kurz, and Peter Huemer
- Subjects
DNA barcoding ,alpine endemism ,primitive moths ,Biology (General) ,QH301-705.5 - Abstract
Incurvaria stangei Rebel, 1903 revised combination, placed without justification in Prodoxidae, is redescribed and transferred back to the Incurvariidae. Male and female genitalia of this south-eastern alpine endemic species are illustrated for the first time. DNA barcode sequences as well as morphological traits support the revised family assignment.
- Published
- 2019
- Full Text
- View/download PDF
4. Total Synthesis of GE81112A: An Orthoester-Based Approach
- Author
-
Scherin Fayad, Ardalan Jafari, Sören M. M. Schuler, Michael Kurz, Oliver Plettenburg, Peter E. Hammann, Armin Bauer, Gerrit Jürjens, and Christoph Pöverlein
- Subjects
Organic Chemistry - Published
- 2023
- Full Text
- View/download PDF
5. Variability of extracorporeal cardiopulmonary resuscitation utilization for refractory adult out-of-hospital cardiac arrest: an international survey study
- Author
-
Patrick J. Coppler, Benjamin S. Abella, Clifton W. Callaway, Minjung Kathy Chae, Seung Pill Choi, Jonathan Elmer, Won Young Kim, Young-Min Kim, Michael Kurz, Joo Suk Oh, Joshua C. Reynolds, Jon C. Rittenberger, Kelly N. Sawyer, Chun Song Youn, Byung Kook Lee, David F. Gaieski, and Korean Hypothermia Network Investigators and the National Post-Arrest Research Consortium
- Subjects
extracorporeal membrane oxygenation ,heart arrest ,cardiopulmonary resuscitation ,Medical emergencies. Critical care. Intensive care. First aid ,RC86-88.9 - Abstract
Objective A growing interest in extracorporeal cardiopulmonary resuscitation (ECPR) as a rescue strategy for refractory adult out-of-hospital cardiac arrest (OHCA) currently exists. This study aims to determine current standards of care and practice variation for ECPR patients in the USA and Korea. Methods In December 2015, we surveyed centers from the Korean Hypothermia Network (KORHN) Investigators and the US National Post-Arrest Research Consortium (NPARC) on current targeted temperature management and ECPR practices. This project analyzes the subsection of questions addressing ECPR practices. We summarized survey results using descriptive statistics. Results Overall, 9 KORHN and 4 NPARC centers reported having ECPR programs and had complete survey data available. Two KORHN centers utilized extracorporeal membrane oxygenation only for postarrest circulatory support in patients with refractory shock and were excluded from further analysis. Centers with available ECPR generally saw a high volume of OHCA patients (10/11 centers care for >75 OHCA a year). Location of, and providers trained for cannulation varied across centers. All centers in both countries (KORHN 7/7, NPARC 4/4) treated comatose ECPR patients with targeted temperature management. All NPARC centers and four of seven KORHN centers reported having a standardized hospital protocol for ECPR. Upper age cutoff for eligibility ranged from 60 to 75 years. No absolute contraindications were unanimous among centers. Conclusion A wide variability in practice patterns exist between centers performing ECPR for refractory OHCA in the US and Korea. Standardized protocols and shared research databases might inform best practices, improve outcomes, and provide a foundation for prospective studies.
- Published
- 2018
- Full Text
- View/download PDF
6. Association of Rapid Response Teams With Hospital Mortality in Medicare Patients
- Author
-
Saket Girotra, Philip G. Jones, Mary Ann Peberdy, Mary S. Vaughan-Sarrazin, Paul S. Chan, Paul Chan, Anne Grossestreuer, Ari Moskowitz, Dana Edelson, Joseph Ornato, Matthew Churpek, Michael Kurz, Monique Anderson Starks, Sarah Perman, and Zachary Goldberger
- Subjects
Resuscitation ,Humans ,Hospital Mortality ,Cardiology and Cardiovascular Medicine ,Medicare ,United States ,Aged ,Heart Arrest ,Hospital Rapid Response Team - Abstract
Background: Although rapid response teams have been widely promoted as a strategy to reduce unexpected hospital deaths, most studies of rapid response teams have not adjusted for secular trends in mortality before their implementation. We examined whether implementation of a rapid response team was associated with a reduction in hospital mortality after accounting for preimplementation mortality trends. Methods: Among 56 hospitals in Get With The Guidelines-Resuscitation linked to Medicare, we calculated the annual rates of case mix–adjusted mortality for each hospital during 2000 to 2014. We constructed a hierarchical log-binomial regression model of mortality over time (calendar-year), incorporating terms to capture the effect of rapid response teams, to determine whether implementation of rapid response teams was associated with reduction in hospital mortality that was larger than expected based on preimplementation trends, while adjusting for hospital case mix index. Results: The median annual number of Medicare admissions was 5214 (range, 408–18 398). The median duration of preimplementation and postimplementation period was 7.6 years (≈2.5 million admissions) and 7.2 years (≈2.6 million admissions), respectively. Hospital mortality was decreasing by 2.7% annually during the preimplementation period. Implementation of rapid response teams was not associated with a change in mortality during the initial year (relative risk for model intercept, 0.98 [95% CI, 0.94–1.02]; P =0.30) or in the mortality trend (relative risk for model slope, 1.01 per year [95% CI, 0.99–1.02]; P =0.30). Among individual hospitals, implementation of a rapid response team was associated with a lower-than-expected mortality at only 4 (7.1%) and higher-than-expected mortality at 2 (3.7%) hospitals. Conclusions: Among a large and diverse sample of US hospitals, we did not find implementation of rapid response teams to be associated with reduction in hospital mortality. Studies are needed to understand best practices for rapid response team implementation, to ensure that hospital investment in these teams improves patient outcomes.
- Published
- 2023
7. A Conserved Hydrophobic Moiety and Helix–Helix Interactions Drive the Self-Assembly of the Incretin Analog Exendin-4
- Author
-
Martin Wolff, Klaus Gast, Andreas Evers, Michael Kurz, Stefania Pfeiffer-Marek, Anja Schüler, Robert Seckler, and Anja Thalhammer
- Subjects
biophysics ,diabetes ,peptides ,oligomerization ,conformational change ,molecular modeling ,Microbiology ,QR1-502 - Abstract
Exendin-4 is a pharmaceutical peptide used in the control of insulin secretion. Structural information on exendin-4 and related peptides especially on the level of quaternary structure is scarce. We present the first published association equilibria of exendin-4 directly measured by static and dynamic light scattering. We show that exendin-4 oligomerization is pH dependent and that these oligomers are of low compactness. We relate our experimental results to a structural hypothesis to describe molecular details of exendin-4 oligomers. Discussion of the validity of this hypothesis is based on NMR, circular dichroism and fluorescence spectroscopy, and light scattering data on exendin-4 and a set of exendin-4 derived peptides. The essential forces driving oligomerization of exendin-4 are helix–helix interactions and interactions of a conserved hydrophobic moiety. Our structural hypothesis suggests that key interactions of exendin-4 monomers in the experimentally supported trimer take place between a defined helical segment and a hydrophobic triangle constituted by the Phe22 residues of the three monomeric subunits. Our data rationalize that Val19 might function as an anchor in the N-terminus of the interacting helix-region and that Trp25 is partially shielded in the oligomer by C-terminal amino acids of the same monomer. Our structural hypothesis suggests that the Trp25 residues do not interact with each other, but with C-terminal Pro residues of their own monomers.
- Published
- 2021
- Full Text
- View/download PDF
8. Small Interfering RNAs Containing Dioxane- and Morpholino-Derived Nucleotide Analogues Show Improved Off-Target Profiles and Chirality-Dependent In Vivo Knock-Down
- Author
-
Armin Hofmeister, Kerstin Jahn-Hofmann, Bodo Brunner, Mike Helms, Christiane Metz-Weidmann, Arne Krack, Michael Kurz, Christoph Heubel, and Sabine Scheidler
- Subjects
Drug Discovery ,Molecular Medicine - Published
- 2022
- Full Text
- View/download PDF
9. Isolation, characterization, and bioactivity profiling of oxazoline containing madurastatin siderophores from Actinomadura sp
- Author
-
Mona-K. Bill, Yolanda Kleiner, Jana L. Flügel, Michael Kurz, Marius Spohn, Michael Marner, Sanja Mihajlovic, Andreas Vilcinskas, Till F. Schäberle, Peter E. Hammann, Maria A. Patras, and Sören M. M. Schuler
- Subjects
Pharmacology ,Drug Discovery - Published
- 2022
- Full Text
- View/download PDF
10. Resuscitation Quality in the ICU
- Author
-
Lara L. Roessler, Mathias J. Holmberg, Rahul D. Pawar, Annmarie T. Lassen, Ari Moskowitz, Anne Grossestreuer, Dana Edelson, Joseph Ornato, Mary Ann Peberdy, Matthew Churpek, Michael Kurz, Monique Anderson Starks, Paul Chan, Saket Girotra, Sarah Perman, and Zachary Goldberger
- Subjects
Pulmonary and Respiratory Medicine ,Cardiology and Cardiovascular Medicine ,Critical Care and Intensive Care Medicine - Published
- 2022
- Full Text
- View/download PDF
11. Framework Conditions for Forming Collaborative Networks on Smart Service Platforms.
- Author
-
Volker Stich, Michael Kurz, and Felix Optehostert
- Published
- 2015
- Full Text
- View/download PDF
12. Antidiabetic profiling of veramycins, polyketides accessible by biosynthesis, chemical synthesis and precursor-directed modification
- Author
-
Denis Dardić, Nils Böhringer, Alberto Plaza, Florian Zubeil, Juliane Pohl, Svenja Sommer, Leo Padva, Jonathan Becker, Maria A. Patras, Mona-Katharina Bill, Michael Kurz, Luigi Toti, Sven W. Görgens, Sören M. M. Schuler, André Billion, Oliver Schwengers, Paulus Wohlfart, Alexander Goesmann, Norbert Tennagels, Andreas Vilcinskas, Peter E. Hammann, Till F. Schäberle, Armin Bauer, and Publica
- Subjects
Organic Chemistry - Abstract
Seven new polyketides, termed veramycins, were isolated from a Streptomyces sp. from the Sanofi microbial strain collection along with their known congeners NFAT-133 and TM-123. Veramycin A, an α-pyrone congener of TM-123 and NFAT-133 showed an increased baseline deoxy-glucose uptake in the absence of insulin in a modified L6 rat skeletal muscle cell line (L6 GLUT4 AS160-like cells). In addition, both compounds slightly increased the sensitivity to insulin in this cell line. Total syntheses of NFAT-133, TM-123 and veramycin A were accomplished starting from a central building block, which bears the three contiguous stereogenic centers of this polyketide family. Our approach enables an efficient, selective and flexible access to all possible isomers of the stereotriad for further exploration of this series as a potential anti-diabetic lead structure as exemplified by the synthesis of an NFAT-133 epimer. Finally, the corresponding biosynthetic gene cluster (BGC) was identified by genome sequencing and gene inactivation. Based on feeding experiments, a biosynthetic pathway was proposed, which enabled access to new veramycin A analogs by precursor-directed biosynthesis.
- Published
- 2022
- Full Text
- View/download PDF
13. Coagulation measures after cardiac arrest (CMACA)
- Author
-
Kim, Hyo Joon, primary, Michael, Kurz, additional, Wee, Jung Hee, additional, Oh, Joo Suk, additional, Kim, Won Young, additional, Cho, In Soo, additional, Lee, Mi Jin, additional, Lee, Dong Hun, additional, Kim, Yong Hwan, additional, and Youn, Chun Song, additional
- Published
- 2023
- Full Text
- View/download PDF
14. Strukturaufklärung, Totalsynthese, In‐Vivo‐Aktivität und Potentieller Biosyntheseweg des Neuen Myxobakteriellen Antibiotikums Corramycin**
- Author
-
Cédric Couturier, Sebastian Groß, Alexander von Tesmar, Judith Hoffmann, Selina Deckarm, Anouchka Fievet, Nelly Dubarry, Thomas Taillier, Christoph Pöverlein, Heike Stump, Michael Kurz, Luigi Toti, Sabine Haag Richter, Dietmar Schummer, Philippe Sizun, Michael Hoffmann, Ram Prasad Awal, Nestor Zaburannyi, Kirsten Harmrolfs, Joachim Wink, Emilie Lessoud, Thierry Vermat, Veronique Cazals, Sandra Silve, Armin Bauer, Michael Mourez, Laurent Fraisse, Corinne Leroi‐Geissler, Astrid Rey, Stéphanie Versluys, Eric Bacqué, Rolf Müller, and Stephane Renard
- Subjects
General Medicine - Published
- 2022
- Full Text
- View/download PDF
15. Syntheses of Morpholine-Based Nucleotide Analogs for Hepatic siRNA Targeting and Stabilization
- Author
-
Christiane Metz-Weidmann, Elsa Pflimlin, Kerstin Jahn-Hofmann, Ziyu Li, Bodo Brunner, Sabine Scheidler, Armin Hofmeister, Merle M Weitzenberg, Arne Krack, Mike W Helms, Oliver Plettenburg, and Michael Kurz
- Subjects
Small interfering RNA ,Acetylgalactosamine ,Morpholino ,Stereochemistry ,Morpholines ,RNA Stability ,Ligands ,01 natural sciences ,Mice ,03 medical and health sciences ,chemistry.chemical_compound ,In vivo ,Morpholine ,Drug Discovery ,Animals ,Prealbumin ,Nucleotide ,RNA, Small Interfering ,Cells, Cultured ,030304 developmental biology ,chemistry.chemical_classification ,0303 health sciences ,Nucleotides ,Chemistry ,Ligand (biochemistry) ,0104 chemical sciences ,Mice, Inbred C57BL ,010404 medicinal & biomolecular chemistry ,Sense strand ,Hepatocytes ,Molecular Medicine ,Female ,RNA Interference ,lipids (amino acids, peptides, and proteins) ,Linker - Abstract
A morpholine-based nucleotide analog was developed as a building block for hepatic siRNA targeting and stabilization. Attachment of an asialoglycoprotein-binding GalNAc ligand at the morpholine nitrogen was realized with different linkers. The obtained morpholino GalNAc scaffolds were coupled to the sense strand of a transthyretin-targeting siRNA and tested for their knockdown potency in vitro and in vivo. A clear structure-activity relationship was developed with regard to the linker type and length as well as the attachment site of the morpholino GalNAc moieties at the siRNA sense strand. Further, simple alkylation of the morpholine nitrogen led to a nucleotide analog, which increased siRNA stability, when used as a double 3'-overhang at the sense strand sequence. Combination of the best morpholino GalNAc building blocks as targeting nucleotides with an optimized stabilizing alkyl-substituted morpholine as 3'-overhangs resulted in siRNAs without any phosphorothioate stabilization in the sense strand and clearly improved the duration of action in vivo.
- Published
- 2021
- Full Text
- View/download PDF
16. Structure Elucidation, Total Synthesis, Antibacterial In Vivo Efficacy and Biosynthesis Proposal of Myxobacterial Corramycin
- Author
-
Cédric Couturier, Sebastian Groß, Alexander von Tesmar, Judith Hoffmann, Selina Deckarm, Anouchka Fievet, Nelly Dubarry, Thomas Taillier, Christoph Pöverlein, Heike Stump, Michael Kurz, Luigi Toti, Sabine Haag Richter, Dietmar Schummer, Philippe Sizun, Michael Hoffmann, Ram Prasad Awal, Nestor Zaburannyi, Kirsten Harmrolfs, Joachim Wink, Emilie Lessoud, Thierry Vermat, Veronique Cazals, Sandra Silve, Armin Bauer, Michael Mourez, Laurent Fraisse, Corinne Leroi‐Geissler, Astrid Rey, Stéphanie Versluys, Eric Bacqué, Rolf Müller, and Stephane Renard
- Subjects
General Chemistry ,Catalysis - Abstract
Herein, we describe the myxobacterial natural product Corramycin isolated from Corallococcus coralloides. The linear peptide structure contains an unprecedented (2R,3S)-γ-N-methyl-β-hydroxy-histidine moiety. Corramycin exhibits anti-Gram-negative activity against Escherichia coli (E. coli) and is taken up via two transporter systems, SbmA and YejABEF. Furthermore, the Corramycin biosynthetic gene cluster (BGC) was identified and a biosynthesis model was proposed involving a 12-modular non-ribosomal peptide synthetase/polyketide synthase. Bioinformatic analysis of the BGC combined with the development of a total synthesis route allowed for the elucidation of the molecule's absolute configuration. Importantly, intravenous administration of 20 mg kg
- Published
- 2022
17. Structure elucidation, biosynthesis, total synthesis and antibacterial in-vivo efficacy of myxobacterial Corramycin
- Author
-
Cédric Couturier, Sebastian Groß, Alexander von Tesmar, Judith Hoffmann, Selina Deckarm, Anouchka Fievet, Nelly Dubarry, Thomas Taillier, Christoph Pöverlein, Heike Stump, Michael Kurz, Luigi Toti, Sabine Haag Richter, Dietmar Schummer, Philippe Sizun, Michael Hoffmann, Ram Prasad Awal, Nestor Zaburannyi, Kirsten Harmrolfs, Joachim Wink, Emilie Lessoud, Thierry Vermat, Veronique Cazals, Sandra Silve, Armin Bauer, Michael Mourez, Laurent Fraisse, Corinne Leroi-Geissler, Astrid Rey, Stéphanie Versluys, Eric Bacqué, Rolf Müller, and Stephane Renard
- Abstract
Herein, we describe the myxobacterial natural product Corramycin (1) isolated from Corallococcus coralloides (C. coralloides). Corramycin is a linear peptide containing an unprecedented (2R,3S) N-methyl-β-hydroxy histidine moiety and exhibiting anti-Gram-negative activity against Escherichia coli. Moreover, we describe the Corramycin biosynthetic gene cluster (BGC) and propose a biosynthesis model involving a 12-modular non-ribosomal peptide synthetase (NRPS)/polyketide synthase (PKS). Bioinformatic analysis of the BGC combined with the development of a total synthesis route allowed for the elucidation of the molecule’s absolute configuration. Furthermore, we show that the uptake of Corramycin in E. coli depends on two transporter systems, SbmA and YejABEF. Importantly, intravenous administration of 30 mg kg 1 of Corramycin in an E. coli mouse infection model resulted in significantly reduced colony forming units (CFU) and in 60 % survival of animals, with no toxic effects observed in vitro or in vivo. Corramycin is thus an intriguing innovative starting point to develop a potent antibacterial drug against hospital acquired infections.
- Published
- 2022
- Full Text
- View/download PDF
18. Photoinduced Decarboxylative Radical Addition Reactions for Late Stage Functionalization of Peptide Substrates
- Author
-
María Méndez, Gerhard Hessler, Ana Villar‐Garea, Angelika Weber, Patricia Fernandez-Rodriguez, Thomas Maier, Michael Kurz, Sven Ruf, Fabien Legros, and Volker Derdau
- Subjects
chemistry.chemical_classification ,Addition reaction ,chemistry ,Organic Chemistry ,Late stage ,Surface modification ,Peptide ,Physical and Theoretical Chemistry ,Combinatorial chemistry - Published
- 2021
- Full Text
- View/download PDF
19. Modular Fragment Synthesis and Bioinformatic Analysis Propose a Revised Vancoresmycin Stereoconfiguration
- Author
-
Lukas M. Wingen, Martina Adamek, Max Schönenbroicher, Dirk Menche, Sebastian Essig, Maximilian Seul, Michael Kurz, Nadine Ziemert, and Stefanie Spindler
- Subjects
Bioinformatics analysis ,Computational biology ,010402 general chemistry ,01 natural sciences ,Biochemistry ,Polyketide ,chemistry.chemical_compound ,Fragment (logic) ,Vancomycin ,Gene cluster ,Physical and Theoretical Chemistry ,Biological Products ,Natural product ,Molecular Structure ,010405 organic chemistry ,business.industry ,Chemistry ,Organic Chemistry ,Computational Biology ,Stereoisomerism ,Modular design ,Anti-Bacterial Agents ,0104 chemical sciences ,Multigene Family ,Polyketides ,business - Abstract
Elaborate fragments of the proposed stereostructure of the complex polyketide antibiotic vancoresmycin have been synthesized in a stereoselective fashion based on a modular and convergent approach. Significant nuclear magnetic resonance differences in one of these subunits compared with the natural product question the proposed stereoconfiguration. Consequently, an extensive bioinformatics analysis of the biosynthetic gene cluster was carried out, leading to a revised stereoconfigurational proposal for this highly potent antibiotic.
- Published
- 2020
- Full Text
- View/download PDF
20. Novel Dioxane and Morpholino Nucleotide Analogues: Syntheses and RNA‐Hybridization Properties
- Author
-
Kerstin Jahn-Hofmann, Sabine Scheidler, Armin Hofmeister, Arne Krack, Michael Kurz, and Armin Müller
- Subjects
Stereochemistry ,Oligonucleotide synthesis ,010402 general chemistry ,Ring (chemistry) ,01 natural sciences ,Biochemistry ,Morpholinos ,Dioxanes ,chemistry.chemical_compound ,Morpholine ,Transition Temperature ,Nucleotide ,Molecular Biology ,RNA, Double-Stranded ,chemistry.chemical_classification ,010405 organic chemistry ,Oligonucleotide ,Organic Chemistry ,Diastereomer ,Nucleic Acid Hybridization ,RNA ,Stereoisomerism ,0104 chemical sciences ,chemistry ,Molecular Medicine ,Chirality (chemistry) ,Thymidine - Abstract
A novel class of nucleotide analogues with a dioxane ring as central scaffold has been developed. Synthetic routes in two diastereomeric series were realized, and the final thymidine analogues were synthesized with common functionalities for the automated oligonucleotide synthesis. The chemical space of the initially derived nucleotides was expanded by changing the central dioxane to analogous morpholine derivatives. This opens up the possibility for further derivatization by attaching different substituents at the morpholine nitrogen. The novel nucleotide building blocks were incorporated into double-stranded RNA sequences, and their hybridization properties investigated by melting-temperature analysis. Both scaffolds, dioxanes and morpholines, had an equal impact on double-strand stability, but Tm values differed depending on the chirality in the six-membered ring.
- Published
- 2020
- Full Text
- View/download PDF
21. Molecular Networking-Guided Discovery and Characterization of Stechlisins, a Group of Cyclic Lipopeptides from a Pseudomonas sp
- Author
-
Sören M. M. Schuler, Michael Marner, Andreas Vilcinskas, Maria A. Patras, Michael Kurz, Frank Förster, Jens Glaeser, Florian Zubeil, Till F. Schäberle, Peter Hammann, and Armin Bauer
- Subjects
Pharmacology ,biology ,010405 organic chemistry ,Computer science ,Organic Chemistry ,Pseudomonas ,Pharmaceutical Science ,Computational biology ,biology.organism_classification ,01 natural sciences ,0104 chemical sciences ,Analytical Chemistry ,010404 medicinal & biomolecular chemistry ,Complementary and alternative medicine ,Downstream (manufacturing) ,Drug Discovery ,Molecular networking ,Molecular Medicine - Abstract
Increasingly sensitive analytical instruments and robust downstream data processing tools have revolutionized natural product research over the past decade. A molecular networking-guided survey led...
- Published
- 2020
- Full Text
- View/download PDF
22. Trichoderma-Derived Pentapeptides from the Infected Nest Mycobiome of the Subterranean Termite Coptotermes testaceus
- Author
-
Markus Oberpaul, Stephan Brinkmann, Marius S. Spohn, Sanja Mihajlovic, Michael Marner, Maria A. Patras, Luigi Toti, Michael Kurz, Peter E. Hammann, Andreas Vilcinskas, Jens Glaeser, and Till F. Schäberle
- Subjects
Trichoderma ,Tandem Mass Spectrometry ,Organic Chemistry ,Molecular Medicine ,Animals ,Isoptera ,Molecular Biology ,Biochemistry ,Mycobiome - Abstract
Termites live in a dynamic environment where colony health is strongly influenced by surrounding microbes. However, little is known about the mycobiomes of lower termites and their nests, and how these change in response to disease. Here we compared the individual and nest mycobiomes of a healthy subterranean termite colony (Coptotermes testaceus) to one infected and ultimately eradicated by a fungal pathogen. We identified Trichoderma species in the materials of both nests, but they were also abundant in the infected termites. Methanolic extracts of Trichoderma sp. FHG000531, isolated from the infected nest, were screened for secondary metabolites by UHPLC-HR MS/MS-guided molecular networking. We identified many bioactive compounds with potential roles in the eradication of the infected colony, as well as a cluster of six unknown peptides. The novel peptide FE011 was isolated and characterized by NMR spectroscopy. The function of this novel peptide family as well as the role of Trichoderma species in dying termite colonies therefore requires further investigation.
- Published
- 2022
23. Identification, Characterization, and Synthesis of Natural Parasitic Cysteine Protease Inhibitors: Pentacitidins Are More Potent Falcitidin Analogues
- Author
-
Stephan Brinkmann, Sandra Semmler, Christian Kersten, Maria A. Patras, Michael Kurz, Natalie Fuchs, Stefan J. Hammerschmidt, Jenny Legac, Peter E. Hammann, Andreas Vilcinskas, Philip J. Rosenthal, Tanja Schirmeister, Armin Bauer, Till F. Schäberle, and Publica
- Subjects
Antimalarials ,Cysteine Proteases ,Tandem Mass Spectrometry ,Plasmodium falciparum ,Molecular Medicine ,Animals ,Humans ,Parasites ,General Medicine ,Cysteine Proteinase Inhibitors ,Biochemistry ,Malaria - Abstract
Protease inhibitors represent a promising therapeutic option for the treatment of parasitic diseases such as malaria and human African trypanosomiasis. Falcitidin was the first member of a new class of inhibitors of falcipain-2, a cysteine protease of the malaria parasite Plasmodium falciparum. Using a metabolomics dataset of 25 Chitinophaga strains for molecular networking enabled identification of over 30 natural analogues of falcitidin. Based on MS/MS spectra, they vary in their amino acid chain length, sequence, acyl residue, and C-terminal functionalization; therefore, they were grouped into the four falcitidin peptide families A-D. The isolation, characterization, and absolute structure elucidation of two falcitidin-related pentapeptide aldehyde analogues by extensive MS/MS spectrometry and NMR spectroscopy in combination with advanced Marfey’s analysis was in agreement with the in silico analysis of the corresponding biosynthetic gene cluster. Total synthesis of chosen pentapeptide analogues followed by in vitro testing against a panel of proteases revealed selective parasitic cysteine protease inhibition and, additionally, low-micromolar inhibition of α-chymotrypsin. The pentapeptides investigated here showed superior inhibitory activity compared to falcitidin.
- Published
- 2022
24. The Discovery and Structure‐Activity Evaluation of (+)‐Floyocidin B and Synthetic Analogs
- Author
-
Till F. Schäberle, Henrik F. König, Christoph Pöverlein, Jannike Klädtke, Andreas Vilcinskas, Jonathan Becker, Michael Marner, Florian Zubeil, Peter Hammann, Michael Kurz, Yolanda Kleiner, Sanja Mihajlovic, Armin Bauer, and Sören M. M. Schuler
- Subjects
Pharmacology ,Biological Products ,biology ,Stereochemistry ,Chemistry ,Organic Chemistry ,Antitubercular Agents ,Absolute configuration ,Total synthesis ,Microbial Sensitivity Tests ,Mycobacterium tuberculosis ,biology.organism_classification ,Biochemistry ,Structure-Activity Relationship ,Drug Discovery ,Humans ,Tuberculosis ,Molecular Medicine ,Structure–activity relationship ,General Pharmacology, Toxicology and Pharmaceutics - Abstract
Tuberculosis represents one of the ten most common courses of death worldwide and the emergence of multidrug-resistant M. tuberculosis makes the discovery of novel anti-tuberculosis active structures an urgent priority. Here, we show that (+)-floyocidin B representing the first example of a novel dihydroisoquinoline class of fungus-derived natural products, displays promising antitubercular hit properties. (+)-Floyocidin B was identified by activity-guided extract screening and its structure was unambiguously determined by total synthesis. The absolute configuration was deduced from a key synthesis intermediate by single crystal X-ray diffraction analysis. A hit series was generated by the isolation of further natural congeners and the synthesis of analogs of (+)-floyocidin B. Extensive biological and physicochemical profiling of this series revealed first structure-activity relationships and set the basis for further optimization and development of this novel antitubercular scaffold.
- Published
- 2021
- Full Text
- View/download PDF
25. Identification, Characterization and Synthesis of Natural Parasitic Cysteine Protease Inhibitors – More Potent Falcitidin Analogs
- Author
-
Sandra Semmler, Stephan Brinkmann, Stefan Hammerschmidt, Till F. Schäberle, Andreas Vilcinskas, Peter Hammann, Natalie Fuchs, Jennifer Legac, Armin Bauer, Michael Kurz, Tanja Schirmeister, Maria A. Patras, Philip J. Rosenthal, and Christian Kersten
- Subjects
chemistry.chemical_classification ,Proteases ,Protease ,biology ,In silico ,medicine.medical_treatment ,Plasmodium falciparum ,Peptide ,biology.organism_classification ,Cysteine protease ,Pentapeptide repeat ,Amino acid ,Biochemistry ,chemistry ,medicine - Abstract
Protease inhibitors represent a promising therapeutic option for the treatment of parasitic diseases such as malaria and human African trypanosomiasis. Falcitidin was the first member of a new class of inhibitors of falcipain-2, a cysteine protease of the malaria parasite Plasmodium falciparum. Using a metabolomics dataset of 25 Chitinophaga strains for molecular networking enabled identification of over 30 natural analogs of falcitidin. Based on MS/MS spectra, they vary in their amino acid chain length, sequence, acyl residue, and C-terminal functionalization; therefore, they were grouped into the four falcitidin peptide families A-D. The isolation, characterization and absolute structure elucidation of two falcitidin-related pentapeptide aldehyde analogs by extensive MS/MS spectrometry and NMR spectroscopy in combination with advanced Marfey’s analysis was in agreement with the in silico analysis of the corresponding biosynthetic gene cluster. Total synthesis of chosen pentapeptide analogs followed by in vitro testing against a panel of proteases revealed selective parasitic cysteine protease inhibition and additionally low-micromolar inhibition of α-chymotrypsin. The pentapeptides investigated here showed superior inhibitory activity compared to falcitidin.
- Published
- 2021
- Full Text
- View/download PDF
26. Design, Synthesis, and Pharmacological Evaluation of Potent Positive Allosteric Modulators of the Glucagon-like Peptide-1 Receptor (GLP-1R)
- Author
-
Elisabeth Defossa, Matthias Löhn, Matthias Schäfer, Pavel Safar, Dietmar Weitz, Kristin Breitschopf, Matthias Lohmann, María Méndez, David S Thorpe, Jens Riedel, Nils Rackelmann, Hartmut Mors, Hans Matter, Michael Kurz, Ziyu Li, Michael Podeschwa, and Sylvain Lebreton
- Subjects
Blood Glucose ,Male ,endocrine system ,Allosteric modulator ,Allosteric regulation ,Pharmacology ,01 natural sciences ,Glucagon-Like Peptide-1 Receptor ,Rats, Sprague-Dawley ,Mice ,03 medical and health sciences ,Allosteric Regulation ,In vivo ,Drug Discovery ,Animals ,Humans ,Hypoglycemic Agents ,Receptor ,Cells, Cultured ,030304 developmental biology ,ADME ,0303 health sciences ,Chemistry ,HEK 293 cells ,Small molecule ,In vitro ,Rats ,0104 chemical sciences ,Mice, Inbred C57BL ,Molecular Docking Simulation ,010404 medicinal & biomolecular chemistry ,HEK293 Cells ,Diabetes Mellitus, Type 2 ,Drug Design ,Molecular Medicine - Abstract
The therapeutic success of peptidic GLP-1 receptor agonists for treatment of type 2 diabetes mellitus (T2DM) motivated our search for orally bioavailable small molecules that can activate the GLP-1 receptor (GLP-1R) as a well-validated target for T2DM. Here, the discovery and characterization of a potent and selective positive allosteric modulator (PAM) for GLP-1R based on a 3,4,5,6-tetrahydro-1H-1,5-epiminoazocino[4,5-b]indole scaffold is reported. Optimization of this series from HTS was supported by a GLP-1R ligand binding model. Biological in vitro testing revealed favorable ADME and pharmacological profiles for the best compound 19. Characterization by in vivo pharmacokinetic and pharmacological studies demonstrated that 19 activates GLP-1R as positive allosteric modulator (PAM) in the presence of the much less active endogenous degradation product GLP1(9-36)NH2 of the potent endogenous ligand GLP-1(7-36)NH2. While these data suggest the potential of small molecule GLP-1R PAMs for T2DM treatment, further optimization is still required towards a clinical candidate.
- Published
- 2019
- Full Text
- View/download PDF
27. Perspectives on Temperature Management
- Author
-
Peter Andrews, Shahed Toossi, Michael Kurz, and Travis C. Jackson
- Subjects
Anesthesiology and Pain Medicine ,Critical Care and Intensive Care Medicine - Published
- 2019
- Full Text
- View/download PDF
28. Makrohämaturie beim antikoagulierten Patienten
- Author
-
Michael Kurz
- Subjects
medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Urinary system ,030232 urology & nephrology ,General Medicine ,Urine ,Cystoscopy ,03 medical and health sciences ,0302 clinical medicine ,Prostate hyperplasia ,030220 oncology & carcinogenesis ,medicine ,Radiology ,business ,Urothelial carcinoma - Abstract
Zusammenfassung. Zusammenfassungen: Die Makrohämaturie sollte als Symptom immer abgeklärt werden, unabhängig davon, ob eine Antikoagulation besteht oder nicht. Die häufigsten Ursachen sind die hämorrhagische Zystitis und bei Männern die Prostatahyperplasie. Die wichtigsten weiteren Differenzialdiagnosen sind das Urothelkarzinom und die Urolithiasis. Zur Primärdiagnostik gehören ein Urinschnelltest, eine Urinkultur und die Sonografie des Harntrakts. Die vollständige Abklärung erfolgt mittels Zystoskopie und Computertomografie. Die Gerinnung sollte immer kontrolliert werden. Leichte Blutungen können ambulant urologisch abgeklärt werden, während Patienten mit hämodynamisch relevanten und/oder tamponierenden Hämorrhagien immer stationär aufgenommen werden sollten. Antikoagulierte, blutende Patienten erfordern auch wegen der internistischen Grunderkrankungen die volle Aufmerksamkeit von Urologen, Internisten und Anästhesisten.
- Published
- 2019
- Full Text
- View/download PDF
29. Real Time Electronic Patient Study Enrollment System in Emergency Room.
- Author
-
Fawaz Ahmad, Rohit Gupta, and Michael Kurz
- Published
- 2005
30. Genomic and chemical decryption of the Bacteroidetes phylum for its potential to biosynthesize natural products
- Author
-
Andreas Vilcinskas, Michael Marner, Jens Glaeser, Marius Spohn, Benedikt Leis, Michael Kurz, Christoph Hartwig, C. Poeverlein, L. Toti, T. F. Schaeberle, Peter Hammann, S. Brinkmann, Armin Bauer, Yolanda Kleiner, Maria A. Patras, and André Billion
- Subjects
chemistry.chemical_compound ,Natural product ,Metabolomics ,chemistry ,Phylum ,Gene cluster ,Bacteroidetes ,Computational biology ,Bacterial genome size ,Biology ,biology.organism_classification ,DNA sequencing ,Chemical space - Abstract
With progress in genome sequencing and data sharing, 1000s of bacterial genomes are publicly available. Genome mining – using bioinformatics tools in terms of biosynthetic gene cluster (BGC) identification, analysis and rating – has become a key technology to explore the capabilities for natural product (NP) biosynthesis. Comprehensively, analyzing the genetic potential of the phylum Bacteroidetes revealed Chitinophaga as the most talented genus in terms of BGC abundance and diversity. Guided by the computational predictions, we conducted a metabolomics and bioactivity driven NP discovery program on 25 Chitinophaga strains. High numbers of peerless strain-specific metabolite buckets confirmed the upfront predicted biosynthetic potential and revealed a tremendous uncharted chemical space. Sourcing this dataset, we isolated the new iron chelating nonribosomally-synthesized cyclic tetradeca- and pentadecalipodepsipeptide antibiotics chitinopeptins with activity against Candida, produced by C. eiseniae DSM 22224 and C. flava KCTC 62435, respectively.TeaserCombination of omics-technologies revealed taxonomical hotspots for specialized metabolites within Bacteroidetes.
- Published
- 2021
- Full Text
- View/download PDF
31. Molecular Networking-Guided Discovery and Characterization of Stechlisins, a Group of Cyclic Lipopeptides from a
- Author
-
Michael, Marner, Maria A, Patras, Michael, Kurz, Florian, Zubeil, Frank, Förster, Sören, Schuler, Armin, Bauer, Peter, Hammann, Andreas, Vilcinskas, Till F, Schäberle, and Jens, Glaeser
- Subjects
Lipopeptides ,Molecular Structure ,Multigene Family ,Pseudomonas ,Candida albicans ,Drug Discovery ,Fatty Acids ,Mycobacterium smegmatis ,Computer Simulation ,Gene Regulatory Networks ,Microbial Sensitivity Tests ,Moraxella catarrhalis ,Anti-Bacterial Agents - Abstract
Increasingly sensitive analytical instruments and robust downstream data processing tools have revolutionized natural product research over the past decade. A molecular networking-guided survey led to the identification of 33 new cyclic lipopeptides (CLPs) from the culture broth of the proteobacterium
- Published
- 2020
32. Carbon-13 synthesis and NMR spectroscopic geometric isomer evaluation to support the filing of teriflunomide
- Author
-
Rolf Hörlein, Volker Derdau, Jens Atzrodt, Dirk Gretzke, Sandrine Turpault, and Michael Kurz
- Subjects
Magnetic Resonance Spectroscopy ,Toluidines ,Hydroxybutyrates ,Nuclear Overhauser effect ,Acetates ,01 natural sciences ,Biochemistry ,030218 nuclear medicine & medical imaging ,Analytical Chemistry ,Isotopomers ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Isomerism ,Drug Discovery ,Teriflunomide ,Nitriles ,Radiology, Nuclear Medicine and imaging ,Potassium Cyanide ,Spectroscopy ,Carbon Isotopes ,010405 organic chemistry ,Organic Chemistry ,Carbon-13 ,0104 chemical sciences ,Hydrocarbons, Brominated ,NMR spectra database ,Ethyl bromoacetate ,chemistry ,Heteronuclear molecule ,Crotonates ,Isotope Labeling ,Physical chemistry ,Cis–trans isomerism - Abstract
The two isotopomers of teriflunomide were synthesized starting from isotopically stable-labeled stocks of [13 C]potassium cyanide and [1-13 C]ethyl bromoacetate. The two 13 C-labeled compounds 1a, b were applied in several NMR studies to study the E/Z ratio in different matrices. In a solution, such as dimethyl sulfoxide (DMSO), a dynamic equilibrium between E/Z-isomers (ratio of 8:92) was determined by initial 13 C-carbon NMR experiments. To get insights into the E/Z ratio of teriflunomide under in vivo conditions, advanced heteronuclear NMR (heteronuclear Overhauser effect spectroscopy [HOESY]) in D2 O and mixtures of D2 O/plasma were performed. Whereas NMR experiments in mixtures of water and plasma failed owing to extreme line broadening, NMR spectra in water at pH 7.4 showed only the Z-isomer.
- Published
- 2020
33. Totalsynthese und Strukturkorrektur des antibiotisch wirksamen Tetrapeptids GE81112A
- Author
-
Sylvain Petit, Sören M. M. Schuler, Raffael C. Wende, Daniel N. Wilson, Frédéric Jeannot, Christoph Pöverlein, Cedric Couturier, Armin Bauer, Michael Kurz, Eric Bacqué, Gerrit Jürjens, Fabian Nguyen, and Peter Hammann
- Subjects
0301 basic medicine ,03 medical and health sciences ,030104 developmental biology ,Chemistry ,General Medicine - Published
- 2018
- Full Text
- View/download PDF
34. Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multidose Formulations
- Author
-
Ralf Elvert, Michael Wagner, Anish Konkar, Herman Schreuder, Anja Pfenninger, Torsten Haack, Andreas W. Herling, Siegfried Stengelin, Martin Bossart, Michael Kurz, Katrin Lorenz, Martin Lorenz, Dieter Kadereit, Andreas Evers, Ulrike Lukasczyk, and Stefania Pfeiffer-Marek
- Subjects
Models, Molecular ,0301 basic medicine ,endocrine system ,Drug Compounding ,Peptide ,Pharmacology ,Glucagon-Like Peptide-1 Receptor ,Structure-Activity Relationship ,03 medical and health sciences ,Protein Domains ,In vivo ,Diabetes mellitus ,Drug Discovery ,Receptors, Glucagon ,medicine ,Humans ,Structure–activity relationship ,Receptor ,chemistry.chemical_classification ,Dose-Response Relationship, Drug ,Drug discovery ,medicine.disease ,Glucagon-like peptide-1 ,HEK293 Cells ,030104 developmental biology ,Solubility ,chemistry ,Molecular Medicine ,Extracellular Space ,Glucagon receptor - Abstract
Novel peptidic dual agonists of the glucagon-like peptide 1 (GLP-1) and glucagon receptor are reported to have enhanced efficacy over pure GLP-1 receptor agonists with regard to treatment of obesity and diabetes. We describe novel exendin-4 based dual agonists designed with an activity ratio favoring the GLP-1 versus the glucagon receptor. As result of an iterative optimization procedure that included molecular modeling, structural biological studies (X-ray, NMR), peptide design and synthesis, experimental activity, and solubility profiling, a candidate molecule was identified. Novel SAR points are reported that allowed us to fine-tune the desired receptor activity ratio and increased solubility in the presence of antimicrobial preservatives, findings that can be of general applicability for any peptide discovery project. The peptide was evaluated in chronic in vivo studies in obese diabetic monkeys as translational model for the human situation and demonstrated favorable blood glucose and body weight lowering effects.
- Published
- 2018
- Full Text
- View/download PDF
35. Physical Modelling of a Stiff String by Numerical Integration.
- Author
-
Michael Kurz and Bernhard Feiten
- Published
- 1996
36. Therapeutic Hypothermia in Postcardiac Arrest
- Author
-
Jon Rittenberger, Michael Kurz, and Kees H. Polderman
- Subjects
03 medical and health sciences ,0302 clinical medicine ,Anesthesiology and Pain Medicine ,030208 emergency & critical care medicine ,030204 cardiovascular system & hematology ,Critical Care and Intensive Care Medicine - Published
- 2017
- Full Text
- View/download PDF
37. Do Sex Differences Exist in the Establishment of 'Do Not Attempt Resuscitation' Orders and Survival in Patients Successfully Resuscitated From In-Hospital Cardiac Arrest?
- Author
-
Sarah M. Perman, Brenda L. Beaty, Stacie L. Daugherty, Edward P. Havranek, Jason S. Haukoos, Elizabeth Juarez‐Colunga, Steven M. Bradley, Timothy J. Fendler, Paul S. Chan, Anne V. Grossestreuer, Ari Moskowitz, Dana Edelson, Joseph Ornato, Katherine Berg, Mary Ann Peberdy, Matthew Churpek, Michael Kurz, Monique Anderson Starks, Saket Girotra, and Zachary Goldberger
- Subjects
Adult ,Male ,medicine.medical_specialty ,Resuscitation ,Adolescent ,cardiac arrest ,030204 cardiovascular system & hematology ,Cohort Studies ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Sex Factors ,Medicine ,Humans ,In patient ,Registries ,Aged ,Resuscitation Orders ,Aged, 80 and over ,Cardiopulmonary Resuscitation and Emergency Cardiac Care ,Go Red for Women Spotlight ,Quality and Outcomes ,business.industry ,Editorials ,030208 emergency & critical care medicine ,methodology ,Middle Aged ,Health Services ,Cardiopulmonary Resuscitation ,United States ,Heart Arrest ,Hospitalization ,Survival Rate ,Cardiopulmonary Arrest ,Editorial ,end‐of‐life care ,Emergency medicine ,Critical illness ,Female ,Cardiology and Cardiovascular Medicine ,business ,qualitative research - Abstract
Background Women have higher utilization of “do not attempt resuscitation” ( DNAR ) orders during treatment for critical illness. Occurrence of sex differences in the establishment of DNAR orders after resuscitation from in‐hospital cardiac arrest is unknown. Whether differences in DNAR use by sex lead to disparities in survival remains unclear. Methods and Results We identified 71 820 patients with return of spontaneous circulation ( ROSC ) after in‐hospital cardiac arrest from the Get With The Guidelines–Resuscitation registry. Multivariable models evaluated the association between de novo DNAR (anytime after ROSC , within 12 hours of ROSC , or within 72 hours of ROSC ) by sex and the association between sex and survival to discharge accounting for DNAR . All models accounted for clustering of patients within hospital and adjusted for demographic and cardiac arrest characteristics. The cohort included 30 454 (42.4%) women, who were slightly more likely than male participants to establish DNAR orders anytime after ROSC (45.0% versus 43.5%; adjusted relative risk: 1.15 [95% CI , 1.10–1.20]; P DNAR status within the first 12 hours (51.8% versus 46.5%; adjusted relative risk: 1.40 [95% CI, 1.30–1.52]; P ROSC (75.9% versus 70.9%; adjusted relative risk: 1.35 [95% CI, 1.26–1.45]; P CI , 0.99–1.02]; P =0.74) was appreciated. Conclusions In patients successfully resuscitated from in‐hospital cardiac arrest, there was no survival difference between men and women while accounting for DNAR . However, women had a higher rate of DNAR status early after resuscitation (
- Published
- 2020
38. Orphan G Protein-Coupled Receptor GPRC5B Controls Smooth Muscle Contractility and Differentiation by Inhibiting Prostacyclin Receptor Signaling
- Author
-
Sarah Tonack, Wencai Zhao, Stefan Günther, Harmandeep Kaur, Nadja Mößlein, Jorge Carvalho, Ramesh Chennupati, Michael Kurz, Nina Wettschureck, Moritz Bünemann, Rui Li, and Stefan Offermanns
- Subjects
Vascular smooth muscle ,Receptors, G-Protein-Coupled ,Contractility ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Physiology (medical) ,Medicine ,Animals ,Humans ,Receptor ,Prostacyclin receptor ,030304 developmental biology ,G protein-coupled receptor ,0303 health sciences ,business.industry ,Specific function ,Cell Differentiation ,Smooth muscle contraction ,Epoprostenol ,Cell biology ,030220 oncology & carcinogenesis ,Cardiology and Cardiovascular Medicine ,business ,Orphan G-Protein Coupled Receptor ,Signal Transduction - Abstract
Background: G protein–coupled receptors are important regulators of contractility and differentiation in vascular smooth muscle cells (SMCs), but the specific function of SMC-expressed orphan G protein–coupled receptor class C group 5 member B (GPRC5B) is unclear. Methods: We studied the role of GPRC5B in the regulation of contractility and dedifferentiation in human and murine SMCs in vitro and in iSM- Gprc5b -KO (tamoxifen-inducible, SMC-specific knockout) mice under conditions of arterial hypertension and atherosclerosis in vivo. Results: Mesenteric arteries from SMC-specific Gprc5b -KOs showed ex vivo significantly enhanced prostacyclin receptor (IP)–dependent relaxation, whereas responses to other relaxant or contractile factors were normal. In vitro, knockdown of GPRC5B in human aortic SMCs resulted in increased IP-dependent cAMP production and consecutive facilitation of SMC relaxation. In line with this facilitation of IP-mediated relaxation, iSM- Gprc5b -KO mice were protected from arterial hypertension, and this protective effect was abrogated by IP antagonists. Mechanistically, we show that knockdown of GPRC5B increased the membrane localization of IP both in vitro and in vivo and that GPRC5B, but not other G protein–coupled receptors, physically interacts with IP. Last, we show that enhanced IP signaling in GPRC5B-deficient SMCs not only facilitates relaxation but also prevents dedifferentiation during atherosclerosis development, resulting in reduced plaque load and increased differentiation of SMCs in the fibrous cap. Conclusions: Taken together, our data show that GPRC5B regulates vascular SMC tone and differentiation by negatively regulating IP signaling.
- Published
- 2020
39. Self-Assembly of Exendin-4-Derived Dual Peptide Agonists is Mediated by Acylation and Correlated to the Length of Conjugated Fatty Acyl Chains
- Author
-
Torsten Haack, Anja Schüler, Michael Wagner, Stefania Pfeiffer-Marek, Robert Seckler, Anja Thalhammer, Michael Kurz, Martin Wolff, Norbert Nagel, Klaus Gast, and Andreas Evers
- Subjects
Circular dichroism ,Magnetic Resonance Spectroscopy ,Acylation ,Pharmaceutical Science ,Lipid-anchored protein ,Peptide ,02 engineering and technology ,030226 pharmacology & pharmacy ,Glucagon-Like Peptide-1 Receptor ,Protein Structure, Secondary ,Hydrophobic effect ,03 medical and health sciences ,0302 clinical medicine ,Glucagon-Like Peptide 1 ,ddc:570 ,Drug Discovery ,Side chain ,Receptors, Glucagon ,Animals ,Amino Acid Sequence ,Protein secondary structure ,Institut für Biochemie und Biologie ,chemistry.chemical_classification ,Circular Dichroism ,Fatty acid ,Lizards ,021001 nanoscience & nanotechnology ,Fatty Acids, Volatile ,Dynamic Light Scattering ,Molecular Weight ,chemistry ,ddc:540 ,Biophysics ,Molecular Medicine ,Exenatide ,0210 nano-technology ,Hydrophobic and Hydrophilic Interactions - Abstract
Dual glucagon-like peptide-1/glucagon receptor agonists have emerged as promising candidates for the treatment of diabetes and obesity. Issues of degradation sensitivity and rapid renal clearance are addressed, for example, by the conjugation of peptides to fatty acid chains, promoting reversible albumin binding. We use combined dynamic and static light scattering to directly measure the self-assembly of a set of dual peptide agonists based on the exendin-4 structure with varying fatty acid chain lengths in terms of apparent molecular mass and hydrodynamic radius (R-S). We use NMR spectroscopy to gain an insight into the molecular architecture of the assembly. We investigate conformational changes of the monomeric subunits resulting from peptide self-assembly and assembly stability as a function of the fatty acid chain length using circular dichroism and fluorescence spectroscopy. Our results demonstrate that self-assembly of the exendin-4-derived dual agonist peptides is essentially driven by hydrophobic interactions involving the conjugated acyl chains. The fatty acid chain length affects assembly equilibria and the assembly stability, although the peptide subunits in the assembly retain a dynamic secondary structure. The assembly architecture is characterized by juxtaposition of the fatty acyl side chains and a hydrophobic cluster of the peptide moiety. This cluster experiences local conformational changes in the assembly compared to the monomeric unit leading to a reduction in solvent exposure. The N-terminal half of the peptide and a C-terminal loop are not in contact with neighboring peptide subunits in the assemblies. Altogether, our study contributes to a thorough understanding of the association characteristics and the tendency toward self-assembly in response to lipidation. This is important not only to achieve the desired bioavailability but also with respect to the physical stability of peptide solutions.
- Published
- 2020
40. [Macrohaematuria in Anticoagulated Patients]
- Author
-
Michael, Kurz
- Subjects
Male ,Carcinoma, Transitional Cell ,Urologic Neoplasms ,Cystitis ,Prostatic Hyperplasia ,Anticoagulants ,Humans ,Cystoscopy ,Hematuria - Abstract
Macrohaematuria in Anticoagulated Patients Abstract. Macrohaematuria should always be clarified as a symptom, regardless of whether anticoagulation exists. The most common causes are haemorrhagic cystitis and in men prostate hyperplasia. The most important other differential diagnoses are urothelial carcinoma and urolithiasis. Primary diagnostics include a rapid urine test, urine culture and sonography of the urinary tract. The complete examination is performed by cystoscopy and computer tomography. Coagulation should always be checked. Light bleeding can be clarified urologically on an outpatient basis, while patients with haemodynamically relevant and/or tamponing haemorrhages should always be admitted on an inpatient basis. Anticoagulated, bleeding patients also require the full attention of urologists, internists and anaesthetists due to the underlying internal diseases.Zusammenfassung. Zusammenfassungen: Die Makrohämaturie sollte als Symptom immer abgeklärt werden, unabhängig davon, ob eine Antikoagulation besteht oder nicht. Die häufigsten Ursachen sind die hämorrhagische Zystitis und bei Männern die Prostatahyperplasie. Die wichtigsten weiteren Differenzialdiagnosen sind das Urothelkarzinom und die Urolithiasis. Zur Primärdiagnostik gehören ein Urinschnelltest, eine Urinkultur und die Sonografie des Harntrakts. Die vollständige Abklärung erfolgt mittels Zystoskopie und Computertomografie. Die Gerinnung sollte immer kontrolliert werden. Leichte Blutungen können ambulant urologisch abgeklärt werden, während Patienten mit hämodynamisch relevanten und/oder tamponierenden Hämorrhagien immer stationär aufgenommen werden sollten. Antikoagulierte, blutende Patienten erfordern auch wegen der internistischen Grunderkrankungen die volle Aufmerksamkeit von Urologen, Internisten und Anästhesisten.
- Published
- 2019
41. Non-linear dynamical signal characterization for prediction of defibrillation success through machine learning.
- Author
-
Sharad Shandilya, Kevin Ward, Michael Kurz, and Kayvan Najarian
- Published
- 2012
- Full Text
- View/download PDF
42. Credit Supply: Are There Negative Spillovers from Banks’ Proprietary Trading?
- Author
-
Michael Kurz and Stefanie Kleimeier
- Subjects
Government ,Capital expenditure ,Loan ,Proprietary trading ,Financial crisis ,Financial market ,Financial system ,Subsidy ,Sample (statistics) ,Business - Abstract
Following the 2008 financial crisis, policy makers considered regulations that restrict banks’ activities which were motivated by concerns that banks use central bank borrowing, government guarantees, or subsidies to fund securities trading instead of lending to the real economy. Using a global sample of 132 major banks from 2003 to 2016, we find that banks’ securities trading is indeed associated with decreased loan supply. Effects are stronger for domestic lending markets, during crisis periods, and in countries with deeper financial markets. However, corporate capital expenditures and employment growth are unaffected, suggesting that policy makers’ concerns are only partly justified.
- Published
- 2019
- Full Text
- View/download PDF
43. Coordination Between Maintenance and Production by Means of Auction Mechanisms for Increased Efficiency of Production Systems
- Author
-
Philipp Jussen, Günther Schuh, Michael Kurz, and Florian Defèr
- Subjects
Economic efficiency ,Interdependence ,Flexibility (engineering) ,Risk analysis (engineering) ,Order (exchange) ,Industrial production ,media_common.quotation_subject ,Production (economics) ,Quality (business) ,Business ,Production system ,media_common - Abstract
In order to cope with the challenges of an increased demand for flexibility, quality and availability of production, maintenance measures provide a major competiveness factor for manufacturing companies. Yet, interdependencies between maintenance and production activities as well as differing target systems within the functional units of an enterprise, especially production and maintenance, raise needs for extended coordination efforts. This paper aims to develop an innovative approach for the coordination between maintenance and production activities for industrial production companies. To achieve this, the novel coordination mechanism is used. It helps to achieve maximised operational availability—for a maximised output of the production system at optimal costs. Based on the developed model, the present paper identifies findings regarding the impact of different maintenance strategies on the medium-term economic efficiency of the production system.
- Published
- 2018
- Full Text
- View/download PDF
44. Abstract 283: Estimating the Impact of Bystander Interventions on Disability-Adjusted Life Years Following Adult Out-of-Hospital Cardiac Arrest in the United States
- Author
-
Ryan A Coute, Brian Nathanson, Ashish Panchal, Michael Kurz, Nathan Haas, Bryan McNally, Robert Neumar, and Timothy Mader
- Subjects
Physiology (medical) ,Cardiology and Cardiovascular Medicine - Abstract
Background: Disability-adjusted life years (DALY) are a common public health metric used to consistently estimate and compare disease burden. The impact of bystander interventions on DALY following out-of-hospital cardiac arrest (OHCA) is unknown. Our objective was to estimate the effect of bystander CPR (B-CPR) and bystander AED (B-AED) application on DALY following OHCA in the United States (U.S.). Methods: DALY were calculated as the sum of years of life lost (YLL) and years lived with disability (YLD) using all adult non-traumatic EMS-treated OHCA from the national CARES database for 2016. A multivariable linear regression model was constructed for effect estimation with DALY values as the outcome and standard Utstein variables as independent variables. Marginal effect estimates for B-CPR and B-AED were derived in models that used all independent variables as main effects. A sensitivity analysis included interaction terms. The analysis for B-CPR was limited to bystander witnessed events. The B-AED analysis was limited to public OHCA events. The marginal effects on DALY were used to derive national estimates of life years saved. Results: A total of 19,324 OHCA cases met study inclusion criteria. The provision of B-CPR was associated with an absolute mean decrease of -0.36 DALY; 95% CI (-0.44, -0.27) per OHCA, when compared to cases without B-CPR (p Conclusion: Bystander interventions are associated with a decrease in DALY following adult OHCA. These results highlight the importance of national bystander CPR and AED education and surveillance.
- Published
- 2018
- Full Text
- View/download PDF
45. From identification to functional characterization of cyriotoxin-1a, an antinociceptive toxin from the spider Cyriopagopus schioedtei
- Author
-
Rémy Béroud, Laurent Bialy, Andrees Bohme, Jean-Marie Chambard, Michel De Waard, Laetitia Lucarain, Lucie Jaquillard, Denis Servent, Stéphane Hourcade, Michel Partiseti, Gerhard Hessler, Stéphanie Combemale, Brigitte Schombert, Michael Kurz, Sophie Fouconnier, Rachid Boukaiba, Tânia C. Gonçalves, Evelyne Benoit, Sanofi R & D, Integrated Drug Discovery, In Vitro Biology & Pharmacology, Service d'Ingénierie Moléculaire pour la Santé (ex SIMOPRO) (SIMoS), Médicaments et Technologies pour la Santé (MTS), Université Paris-Saclay-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)-Université Paris-Saclay-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Institut des Neurosciences Paris-Saclay (NeuroPSI), Université Paris-Sud - Paris 11 (UP11)-Centre National de la Recherche Scientifique (CNRS), Smartox Biotechnology, Université Joseph Fourier - Grenoble 1 (UJF), Sanofi-Aventis Deutschland GmbH, Neuroscience Therapeutic Area, UCB BioPharma, INSERM U836, équipe 3, Canaux calciques, fonctions et pathologies, Grenoble Institut des Neurosciences (GIN), Université Joseph Fourier - Grenoble 1 (UJF)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Joseph Fourier - Grenoble 1 (UJF)-Institut National de la Santé et de la Recherche Médicale (INSERM), unité de recherche de l'institut du thorax UMR1087 UMR6291 (ITX), Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), ANR-11-LABX-0015,ICST,Canaux ioniques d'intérêt thérapeutique(2011), Unité de recherche de l'institut du thorax (ITX-lab), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN), BENOIT, Evelyne, and Laboratoires d'excellence - Canaux ioniques d'intérêt thérapeutique - - ICST2011 - ANR-11-LABX-0015 - LABX - VALID
- Subjects
0301 basic medicine ,[SDV]Life Sciences [q-bio] ,Narcotic Antagonists ,Pain ,Spider Venoms ,Peptide ,Venom ,Voltage-Gated Sodium Channels ,Pharmacology ,Cell Line ,03 medical and health sciences ,chemistry.chemical_compound ,Mice ,0302 clinical medicine ,In vivo ,Animals ,Humans ,[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC] ,chemistry.chemical_classification ,Analgesics ,Sodium channel ,Spiders ,[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences ,Research Papers ,In vitro ,[SDV] Life Sciences [q-bio] ,[SDV.SP] Life Sciences [q-bio]/Pharmaceutical sciences ,Electrophysiology ,Disease Models, Animal ,030104 developmental biology ,HEK293 Cells ,chemistry ,[SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology ,Tetrodotoxin ,[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology ,[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC] ,Female ,Inhibitor cystine knot ,030217 neurology & neurosurgery ,Sodium Channel Blockers - Abstract
Background and purpose The NaV 1.7 channel is highly expressed in dorsal root ganglia of the sensory nervous system and plays a central role in the pain signalling process. We investigated a library prepared from original venoms of 117 different animals to identify new selective inhibitors of this target. Experimental approach We used high throughput screening of a large venom collection using automated patch-clamp experiments on human voltage-gated sodium channel subtypes and then in vitro and in vivo electrophysiological experiments to characterize the active peptides that have been purified, sequenced, and chemically synthesized. Analgesic effects were evaluated in vivo in mice models. Key results We identified cyriotoxin-1a (CyrTx-1a), a novel peptide isolated from Cyriopagopus schioedtei spider venom, as a candidate for further characterization. This 33 amino acids toxin belongs to the inhibitor cystine knot structural family and inhibits hNaV 1.1-1.3 and 1.6-1.7 channels in the low nanomolar range, compared to the micromolar range for hNaV 1.4-1.5 and 1.8 channels. CyrTx-1a was 920 times more efficient at inhibiting tetrodotoxin (TTX)-sensitive than TTX-resistant sodium currents recorded from adult mouse dorsal root ganglia neurons and in vivo electrophysiological experiments showed that CyrTx-1a was approximately 170 times less efficient than huwentoxin-IV at altering mouse skeletal neuromuscular excitability properties. CyrTx-1a exhibited an analgesic effect in mice by increasing reaction time in the hot-plate assay. Conclusions and implications The pharmacological profile of CyrTx-1a paves the way for further molecular engineering aimed to optimize the potential antinociceptive properties of this peptide.
- Published
- 2018
- Full Text
- View/download PDF
46. Characteristics and outcomes of maternal cardiac arrest: A descriptive analysis of Get with the guidelines data
- Author
-
Carolyn M. Zelop, Sharon Einav, Jill M. Mhyre, Steven S. Lipman, Julia Arafeh, Richard E. Shaw, Dana P. Edelson, Farida M. Jeejeebhoy, Anne Grossestreuer, Ari Moskowitz, Dana Edelson, Joseph Ornato, Katherine Berg, Mary Ann Peberdy, Matthew Churpek, Michael Kurz, Monique Anderson Starks, Paul Chan, Saket Girotra, Sarah Perman, and Zachary Goldberger
- Subjects
Adult ,medicine.medical_specialty ,Resuscitation ,Pregnancy Complications, Cardiovascular ,Electric Countershock ,030204 cardiovascular system & hematology ,Emergency Nursing ,Return of spontaneous circulation ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,030202 anesthesiology ,Pregnancy ,Epidemiology ,medicine ,Humans ,Hospital Mortality ,Registries ,Asystole ,Descriptive statistics ,business.industry ,medicine.disease ,Cardiopulmonary Resuscitation ,Heart Arrest ,Treatment Outcome ,Emergency medicine ,Pulseless electrical activity ,Ventricular fibrillation ,Cohort ,Practice Guidelines as Topic ,Emergency Medicine ,Female ,Cardiology and Cardiovascular Medicine ,business - Abstract
Background Maternal mortality has risen in the United States in the twenty-first century, yet large cohort data of maternal cardiac arrest (MCA) are limited. Objective We sought to describe contemporary characteristics and outcomes of in-hospital MCA. Methods We queried the American Heart Association’s Get with the Guidelines Resuscitation voluntary registry from 2000 to 2016 to identify cases of maternal cardiac arrest. All index cardiac arrests occurring in women aged 18–50 with a patient illness category designated as obstetric or location of arrest occurring in a delivery suite were included. Institutional review deemed that this research was exempt from ethical approval. Results A total of 462 index events met criteria for MCA, with a mean age of 31 ± 7 years and a racial distribution of: 49.4% White, 35.3% Black and 15.3% Other/Unknown. While 32% had no pre-existing conditions or physiologic disorders, respiratory insufficiency (36.1%) and hypotension/hypoperfusion (33.3%) were the most common antecedent conditions. In most cases, the first documented pulseless rhythm was non-shockable; pulseless electrical activity (50.8%) or asystole (25.6%). Only 11.7% presented with a shockable rhythm; ventricular fibrillation (6.5%) or pulseless ventricular tachycardia (5.2%) while the initial pulseless rhythm was unknown in 11.9% of cases. Return of spontaneous circulation occurred in 73.6% but 68 (14.7%) had more than one arrest. The rate of survival to discharge was 40.7% overall; 37.3% with non-shockable rhythms, 33% with shockable rhythms and 64.3% with unknown presenting rhythms. Conclusions Maternal survival at hospital discharge in this cohort was less than 50%, lower than rates reported in other epidemiological datasets. More research is required in maternal resuscitation science and translational medicine to continue to improve outcomes and understand maternal mortality.
- Published
- 2018
47. Produktion mariner Naturstoffe aus der Klasse der Bengamide in Myxobakterien: Biosynthese und Struktur-Aktivitäts-Beziehungen
- Author
-
Frederico Nardi, Jean-Paul Nicolas, Laurent Debussche, Loreley Calvet, Irene Kochems, Mark Brönstrup, Stefan Pelzer, Michael Kurz, Tietgen Heiko, Peer Lukat, Rolf Müller, Dietmar Schummer, Jidong Zhang, Agnes Mühlenweg, Holger Hoffmann, Patricia Vrignaud, Valerie Czepczor, Silke C. Wenzel, and Sabine Haag-Richter
- Subjects
General Medicine - Abstract
Bengamide, aus marinen Schwammen stammende und als Inhibitoren der Methionin-Aminopeptidase (MetAP) charakterisierte Naturstoffe, wurden intensiv als Wirkstoffe gegen Krebs erforscht. In einem multidisziplinaren Forschungsprojekt haben wir die Bereitstellung von Bengamiden uber Fermentation des terrestrischen Myxobakteriums M. virescens, die Aufklarung ihrer Biosynthese und die Optimierung ihrer Eigenschaften als Arzneistoff-Leitstrukturen untersucht. Die Charakterisierung des Biosyntheseweges zeigte auf, dass bakterielle Resistenz gegenuber Bengamiden durch Leu154 des myxobakteriellen MetAP-Proteins vermittelt wird, und ermoglichte den Transfer des gesamten Biosynthesegenclusters in den geeigneteren Produktionsstamm M. xanthus DK1622. Eine Kombination aus Semisynthese mikrobiell gewonnener Bengamide und Totalsynthese fuhrte zum optimierten Derivat 8 a. Die nanomolare zellulare Wirksamkeit und die hohe metabolische Stabilitat waren mit einer verbesserten Halbwertszeit in Mausen sowie mit Antitumor-Effizienz in einem Melanom-Mausmodell verbunden.
- Published
- 2015
- Full Text
- View/download PDF
48. Production of the Bengamide Class of Marine Natural Products in Myxobacteria: Biosynthesis and Structure–Activity Relationships
- Author
-
Loreley Calvet, Sabine Haag-Richter, Frederico Nardi, Peer Lukat, Patricia Vrignaud, Jean-Paul Nicolas, Jidong Zhang, Irene Kochems, Silke C. Wenzel, Mark Brönstrup, Tietgen Heiko, Michael Kurz, Laurent Debussche, Dietmar Schummer, Valerie Czepczor, Stefan Pelzer, Rolf Müller, Holger Hoffmann, Agnes Mühlenweg, and Helmholtz-Institut für pharmazeutische Forschung Saarland, Universitätscampus E8.1, 66123 Saarbrücken.
- Subjects
Stereochemistry ,Melanoma, Experimental ,Marine Biology ,Catalysis ,Mice ,Structure-Activity Relationship ,chemistry.chemical_compound ,Myxobacteria ,Biosynthesis ,Gene cluster ,Animals ,Structure–activity relationship ,Myxococcales ,Biological Products ,Methionine ,biology ,Drug discovery ,Total synthesis ,Azepines ,General Chemistry ,biology.organism_classification ,Semisynthesis ,Porifera ,Mice, Inbred C57BL ,chemistry ,Area Under Curve ,Female ,Half-Life - Abstract
The bengamides, sponge-derived natural products that have been characterized as inhibitors of methionine aminopeptidases (MetAPs), have been intensively investigated as anticancer compounds. We embarked on a multidisciplinary project to supply bengamides by fermentation of the terrestrial myxobacterium M. virescens, decipher their biosynthesis, and optimize their properties as drug leads. The characterization of the biosynthetic pathway revealed that bacterial resistance to bengamides is conferred by Leu 154 of the myxobacterial MetAP protein, and enabled transfer of the entire gene cluster into the more suitable production host M. xanthus DK1622. A combination of semisynthesis of microbially derived bengamides and total synthesis resulted in an optimized derivative that combined high cellular potency in the nanomolar range with high metabolic stability, which translated to an improved half-life in mice and antitumor efficacy in a melanoma mouse model.
- Published
- 2015
- Full Text
- View/download PDF
49. Biosynthetic Studies of Telomycin Reveal New Lipopeptides with Enhanced Activity
- Author
-
Jennifer Herrmann, Alexandre Froidbise, Michael Kurz, Matthias Schiell, Peter Hammann, Luigi Toti, Mark Brönstrup, Chengzhang Fu, Armin Bauer, Dietmar Schummer, Guillaume Mondésert, Rolf Müller, Joachim Wink, and Lena Keller
- Subjects
Hydroxylation ,Biochemistry ,Streptomyces ,Catalysis ,Amidohydrolases ,Mixed Function Oxygenases ,Streptomyces canus ,Lipopeptides ,chemistry.chemical_compound ,Colloid and Surface Chemistry ,Bacterial Proteins ,Biosynthesis ,Nonribosomal peptide ,Gene cluster ,Peptide Synthases ,Streptomyces albus ,chemistry.chemical_classification ,DNA ligase ,biology ,General Chemistry ,biology.organism_classification ,Anti-Bacterial Agents ,Biosynthetic Pathways ,Amino acid ,chemistry ,Multigene Family ,Peptides - Abstract
Telomycin (TEM) is a cyclic depsipeptide antibiotic active against Gram-positive bacteria. In this study, five new natural telomycin analogues produced by Streptomyces canus ATCC 12646 were identified. To understand the biosynthetic machinery of telomycin and to generate more analogues by pathway engineering, the TEM biosynthesis gene cluster has been characterized from S. canus ATCC 12646: it spans approximately 80.5 kb and consists of 34 genes encoding fatty acid ligase, nonribosomal peptide synthetases (NRPSs), regulators, transporters, and tailoring enzymes. The gene cluster was heterologously expressed in Streptomyces albus J1074 setting the stage for convenient biosynthetic engineering, mutasynthesis, and production optimization. Moreover, in-frame deletions of one hydroxylase and two P450 monooxygenase genes resulted in the production of novel telomycin derivatives, revealing these genes to be responsible for the specific modification by hydroxylation of three amino acids found in the TEM backbone. Surprisingly, natural lipopeptide telomycin precursors were identified when characterizing an unusual precursor deacylation mechanism during telomycin maturation. By in vivo gene inactivation and in vitro biochemical characterization of the recombinant enzyme Tem25, the maturation process was shown to involve the cleavage of previously unknown telomycin precursor-lipopeptides, to yield 6-methylheptanoic acid and telomycins. These lipopeptides were isolated from an inactivation mutant of tem25 encoding a (de)acylase, structurally elucidated, and then shown to be deacylated by recombinant Tem25. The TEM precursor and several semisynthetic lipopeptide TEM derivatives showed rapid bactericidal killing and were active against several multidrug-resistant (MDR) Gram-positive pathogens, opening the path to future chemical optimization of telomycin for pharmaceutical application.
- Published
- 2015
- Full Text
- View/download PDF
50. Targeting DnaN for tuberculosis therapy using novel griselimycins
- Author
-
Eric L. Nuermberger, Michel Geslin, Nicole C. Ammerman, Evelyne Fontaine, Florence Bordon-Pallier, Holger Hoffmann, Peer Lukat, Nestor Zaburannyi, Mark Brönstrup, Rolf Müller, Hans Matter, Dirk W. Heinz, Sandeep Tyagi, Sylvie Sordello, Armin Bauer, Michael Kurz, Kai Borchers, Sylvie Klieber, Courtemanche Gilles, Jacques H. Grosset, Silke C. Wenzel, Markus Kohlmann, Angela Kling, Christine Lair, María Belén Barrio, Jennifer Herrmann, Sophie Lagrange, Deepak V. Almeida, Laurent Fraisse, Claudia König, Martin Gerlitz, and Peter Hammann
- Subjects
Multidisciplinary ,DNA clamp ,Tuberculosis ,biology ,medicine.drug_class ,business.industry ,DNA polymerase ,Antibiotics ,dnaN ,biology.organism_classification ,medicine.disease ,Virology ,Mycobacterium tuberculosis ,Streptomycin ,Immunology ,Gene duplication ,medicine ,biology.protein ,business ,medicine.drug - Abstract
New for old—TB drug development Tuberculosis (TB) is a global health threat for which there is only lengthy drug treatment. Patients need to consume multiple tablets over several months and frequently fail to complete their treatment. Consequently, drug-resistant strains of the pathogen have emerged, which add to the threat. Kling et al. revisited a natural product called griselimycin, extracted from the same organism that produced the prototype anti-TB drug, streptomycin. Unmodified griselimycin has poor pharmacological properties. However, one synthetic derivative had improved oral uptake and penetrated cells of the immune system that harbor the TB mycobacterium. In combination with other drugs, the griselimycin derivative showed high potency in mice with TB. Science , this issue p. 1106
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.